Global Alliance for Vaccines and Immunization. WHAT IS GAVI ?

Slides:



Advertisements
Similar presentations
KENYA HEALTH SECTOR PARTNERSHIP Third IHP+ Country Health Sector Teams Meeting Brussels, December 2010.
Advertisements

Synergies between the GAVI Alliance and health systems strengthening Dr. Craig Burgess, GAVI Secretariat 29 May 2008.
Global Alliance for Vaccines and Immunization. n An Alliance u Traditional and new partners u Public and private sector n Partners have in common: u Situation.
Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.
The Effectiveness of Global Health Partnerships Findings and Lessons from a World Bank Evaluation of Global Health Programs Uma Lele April 14, 2005.
Global Measles and Rubella Strategic Plan
Universal Coverage – Can we guarantee health for all? 3 – 4 October 2011, Kuala Lumpur Nossal perspective.
Immunization Services DR. KANUPRIYA CHATURVEDI DR.S.K. CHATURVEDI.
Santiago Cornejo GAVI HSS and Future Joint Programming with the World Bank and the Global Fund to fight AIDS, TB and Malaria Cusco, 10 November 2009.
Overview of the Global Fund: Guiding Principles Grant Cycle / Processes & Role of Public Private Partnerships Johannesburg, South Africa Tatjana Peterson,
Supporting Integrated Health Systems Strengthening A CIDA Perspective.
National Strategies to Achieve Universal Access to Reproductive Health: Scaling Up IPCI/ICPD Meeting Bangkok, Thailand 22 November 2006 Stan Bernstein.
Critical conversations in Public-private partnerships Dr Ranjana Kumar 1 st November 2007.
Advance Market Commitments for Vaccines Carlo Monticelli International Financial Relations Ministero dell’Economia e delle Finanze.
Update on Vaccines not Included in this Tender: Rotavirus Vaccines Pre Tender Meeting UNICEF Supply Division, 10-11th December 2008 Ann Ottosen.
Working Together to Improve Global Health
1 European Region Global Alliance for Vaccines & Immunization Overview on the Implementation Of the Introduction of New / Under-used Vaccines.
Pre Tender Meeting UNICEF Supply Division, December 2008 Rob Matthews UNICEF Vaccine Procurement for Developing Countries.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
Post-2015 Development Agenda Emerging Cross-Cutting Themes December 5, 2013.
1 Collective Efficiencies Development Finance Architecture Workshop Prerna Banati - July
OIC-SHPA & Vaccines Need Assessment in OIC Member Countries
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
Process of Development of Five Year Strategic Plan for Child Health Development Dr Myint Myint Than Deputy Director (WCHD) Department of Health.
Civil Society in Decision Making for Immunization Policies: the example of National Immunization Technical Advisory Groups (NITAGs) Center for Vaccine.
Total health ODA commitments, US$ Billions.
A Comprehensive Policy framework for the National Immunization Programme Dr Nihal Abeysinghe, [M.B.,B.S., MSc, M.D.] Chief Epidemiologist, Ministry of.
Measles Initiative Financing February 28, 2007 Washington, D.C. Andrea Gay UN Foundation for Measles Partners.
Sources of Support and What They Mean to the Field Dr. Duff Gillespie June 15 th, 2002 Africa SOTA, Nairobi.
THE ROLE OF STOP TB GHANA PARTNERSHIP Chief Austin A. Obiefuna National Coordinator SECRETARIAT CO-HOSTED BY AFRO GLOBAL ALLIANCE (GH) & GHANA SOCIETY.
What is “Reaching Every District” (RED) in Immunization? A brief overview Information from the global immunization partnership presented by Lora Shimp.
The Global Fund- structure, function and evolution February 18, 2008.
IMMUNIZATION IN UGANDA Dan Wamanya IMMUNIZATION IN UGANDA Dan Wamanya USAID/Uganda.
Public-Private Partnerships -Selected Experiences in the Western Pacific & Cambodia- National Forum on Public-Private Partnership in Health 7 November,
SECTOR POLICY SUPPORT PROGRAMMES A new methodology for delivery of EC development assistance. 1.
GAVI/Vaccine Fund Support to Improve Injection Safety On behalf of the Injection Safety sub-group.
Multi-Year Plans Strengthening immunization systems and introduction of hepatitis B vaccine in Central Europe and the Newly Independent States St. Petersburg,
Polio Eradication  Although the number of endemic countries is at an all-time low in 2002, the actual number of cases was approximately four times higher.
DRAFT V1 National Vaccine Supply Chain Innovations: Country Commitment to Ownership, Sustainability & Impact GAVI Partners’ Forum WHO – UNICEF – GAVI -
Current Status of Immunization Service Delivery in Africa Mary Harvey AFR/SD/HRD SOTA/PHN Meeting June 13, 2002.
Conclusions of the meeting and closing remarks. Chronology 1981Hepatitis B vaccine becomes available 1991World Health Assembly resolution call for the.
Measles Initiative Management and Financing September 13, 2011.
Workshop on the Vaccine Fund (Global Fund) 1. Structure, Sub-Accounts and Application Process 2. After application and approval – Reports and Monitoring.
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
The Global Fund and Southern Africa A review of the structures and grants in southern Africa.
WHO Regional Office for Europe Update on WHO GAVI European Regional Working Group and hepatitis B Immunization Viral Hepatitis Prevention Board Meeting.
AMC Governance and Institutional Support. Objectives Build on existing capacity Ensure appropriate independence and credibility through transparency,
Resource Mobilization and Awareness Working Group Mercedes Mas de Xaxás Population Action International.
Status of EPI In Guinea DR. Mariama BAH Child Survival Advisor USAID/Guinea June 13, 2002.
1 SUPPLY DIVISION Procurement and Supply Management Technical Assistance.
T h e A A A H Asia-Pacific Action Alliance on Human Resources for Health.
WHO EURO In Country Coordination and Strengthening National Interagency Coordinating Committees.
Global Fund Grants To SOTA Countries NO YR1 ALL Yrs TIER 113 $91 mil $461mil TIER 22 (5) $70 mil $443 mil _________________________________________________________________________.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Regional Centers for Evaluation Capacity Development Regional Centers for Evaluation Capacity Development A Multilateral Initiative June 2009.
UPDATE ON GAVI ALLIANCE, THE GLOBAL FUND AND WORLD BANK COLLABORATIVE EFFORT FOR MORE EFFECTIVE HSS SEPTEMBER, 2009 Exploring a potential common platform.
Injection Safety in the Context of and. “The only thing standing in the way of saving millions of additional kids is ensuring an adequate supply of vaccines.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
Elaine Ireland Global Health Advocacy Officer, International HIV/AIDS Alliance Rome, 9 th February Delivering Effective Aid for Health: International Health.
GAVI, IFFIm & Vaccine Bonds Overview International Finance ’14 Michelle Han 132SIS48.
"Learning and achievements of SWA Global platform and its relevance to achieving Hygiene and Sanitation Development in India" India WASH Summit 17 th February.
Vaccine Development, Innovations and Investments Oslo Malaria Conference, “Getting To Zero” Jean Stéphenne, Chairman and President GlaxoSmithKline Biologicals.
MOH 2 February Identify needs Prioritize needs Finalize list of endorsed needs Submit needs to MOPAD Consult with donor Negotiation (intra- and.
Rotary’s PolioPlus Program The Goal of Rotary is the Global Eradication of Polio and Certification. APHA November 2007 John Sever, M.D., PhD.
IHP+ First Steering Committee Meeting 15 January 2014
Primary Health Care Improvement Global Stakeholder Meting, Geneva
Millennium Development Goals (MDGs)
Developing a Financial Sustainability Plan for Cambodia
Presentation transcript:

Global Alliance for Vaccines and Immunization

WHAT IS GAVI ?

n An Alliance u Traditional and new partners u Public and private sector n Partners have in common: u Situation Analysis u Vision u Set of strategic objectives What is GAVI ?

Situation analysis: Three Gaps +Stagnation of immunization coverage with decline in certain countries and regional discrepancies + Lack of introduction into the poorer developing countries of newly-developed vaccines against major child killers + Limited investment into vaccine research for diseases with high burden in developing countries

Vision: GAVI Mission “To save children’s lives and protect people’s health through the widespread use of vaccines with a particular emphasis on developing countries”

Five Strategic Objectives +Improve access to sustainable immunization services +Expand use of all existing cost-effective vaccines +Accelerate introduction of new vaccines +Accelerate R&D on vaccines for developing countries, (HIV/AIDS, malaria and tuberculosis ) +Make immunization coverage a centrepiece in international development efforts

Milestones +By 2002, 80% countries with adequate delivery system will introduce Hepatitis B vaccine and all countries by By 2005, 80% developing countries will have routine immunization coverage of at least 80% in all districts +By 2005, 50% of poorest countries with high burden of disease and adequate delivery systems will have introduced Hib vaccine +By 2005, the vaccine efficacy and BOD will be known for all regions for rotavirus and pneumococcal vaccines, and mechanisms identified to make the vaccines available to poorest countries

GAVI and THE VACCINE FUND

n Countries (Developing and industrialised) n Agencies (UNICEF, WHO) n Development Banks (World Bank, ADB, AB) n Industry n Technical Agencies (CDC, NIH) n Foundations (Bill and Melinda Gates, Rockefeller, Mérieux...) n NGOs (Path/CVP, AMP...) n Academia WHO is GAVI?

How does GAVI work ? GAVI Board 15 members High-Level : Institutional Commitment Secretariat Monthly Tele/Video Conferences 3 meetings per year Weekly Tele/Video Conferences 5-6 Meetings per year 10 members Joint policy development, Agency workplans Small team, Funded by partner fees Coordination Responsive to Alliance needs Working Group

How does GAVI work ? Task Forces : u Advocacy (UNICEF) u Country Coordination (WHO) u Financing (World Bank and USAID) u R&D (Academia, Industry, WHO) Regional Groups u Africa (2), u East Asia-Pacific, u South Asia, u Middle East and ….

Strengthened Immunization Services and New Vaccines Delivered in Countries Vaccine procurement The Vaccine Fund Independent Board for fundraising & management Working Capital Account (at UNICEF) for vaccine procurement and resource disbursement Three Sub-accounts: Financial Tools: Shares, matching grants Vaccines & Safe injection materials Immunization services R & D (not active) GAVI Board Establishes Principles, recommendations on fund allocation Contributors Gates Foundation USA, UK, Norway, Netherlands, DK $$$ The Vaccine Fund

THE VACCINE FUND

Requirements for Vaccine Fund support n Eligibility u Countries with < US$ 1,000 GNP / capita n Assessment Criteria u Functioning collaborative mechanism (e.g., ICC) u Immunization assessment within last three years u Multi-year plan for immunization n Large countries u Special arrangements for China, India and Indonesia

Support for new and under-used vaccines Support for immunization services and new and under-used vaccines Support for immunization services DTP3 coverage >80% DTP3 coverage 50% - 80% DTP3 coverage <50% Basic Conditions GNP/capita < US$ 1000 ICC or equivalent Immunization assessment in last 3 years Multi-year plan for immunization What will the Vaccine Fund finance ?

New and under-used vaccines : Principles n Hepatitis B globally n Hib vaccine for Africa, Latin America, Middle East & where evidence exists n Yellow fever where recommended in Africa & South America u even when DTP3<50% n Safe injection equipment: u auto-disable syringes and safety boxes ‘bundled’ with vaccines shipped to countries n Combination vaccines u priority to weakest programmes

Immunization services sub-account:  Add to pool of existing funding  Invest in advance, on the basis of set targets for the improvement of the programme  Reward progress according to performance  Monitor progress by reporting of district performance, according to standard indicators and annual review to ICC, to GAVI partners  Delegate allocation of funds through government, partner agency, or other ICC mechanism - ‘no strings’, no international input monitoring system.

Functioning coordination mechanism (ICC) n Senior Chair from MOH as confirmed by membership and minutes n Broad terms of reference, covering all aspects of immunization, including polio, general EPI and new vaccines introduction : n Regular meetings (minutes) n Broad partnership ë In many cases, ICCs will require strengthening : staff budgets, etc..

Recent assessment of immunization programmes n Are recommendations being implemented ? (reflected in the plan) n Surveillance (including AFP surveillance) n Safety of immunization (injections, waste management) n Cold chain, logistics, vaccine wastage n Financing

Multi-year plan for immunization n Reflect recommendations of the assessment n Consistent with global polio eradication strategies, measles control and MNT elimination n Plan to ensure safety of injections n Targets for improving coverage and reaching unreached n Disease surveillance n New vaccines introduction n Budget forecast, financing plan and sustainability strategy

How are applications assessed ? n Independent review committee (9 members) n Mali, Tunisia, Philippines, Ghana, Tanzania, Bahamas, USA, Thailand, Slovenia n Majority from developing countries n Strong immunization programme management experience n Meets for 10 days- 2 weeks for in-depth review n each application reviewed by 3 members n Members declare any conflict of interest n recommendations to the GAVI Board

ROLES AND RESPONSIBILITIES OF PARTNERS

What is expected of countries ? Increased commitment to strengthen immunization u Establish, strengthen and manage an Inter-Agency Coordination mechanism u Develop,monitor and update a multi-year plan for immunization including: F Polio eradication F Injection safety F Resource mobilization plan u Negotiate and secure financing from F National Budgets (including loans) F Bilateral and Multi-lateral Partners’ support F The Global Fund for Children’s vaccines

What are Partners responsible for? Increased commitment to immunization u Increased coordination of technical and financial support u Procurement of vaccines and goods u Consultants, Funding u Training (technical, management, financing) u Capacity building to develop regional expertise u Networking with other countries to learn from experiences

Status of 74 eligible countries June 2001 * (GNP per capita < US$ 1,000) June approvals Approved: Uzbekistan Approved with clarification: Turkmenistan, Albania, Tajikistan Conditional Approval: Bosnia & Herz

Financial commitments to GAVI objectives… so far ! US $ 750 million : Gates Foundation (5 yrs) US $ 50 Million : USA (FY 2001) GB £ 3 million : UK NKr 1 billion : Norway (5 yrs) NGL 250 million : Netherlands (5 yrs) Dkr 25 million : Denmark

Next Milestones Progress report : 1 October 2001 Mid term review : 1 October 2002 Next reviews of applications: n November 2001, ….until Spring 2002 * All applications approved before Spring 2002 will result in 5 years support